The Philippine Cancer Society , Inc. (PCSI) was registered with the SEC as a private, non-stock, non-profit corporation on December 22,1956. Its amended by- laws and Articles of Incorporation in compliance with the BIR and SEC requirements were submitted to SEC in 2013. Since its inception to date, the PCSI focuses its efforts towards three primary advocacies on cancer – prevention and early detection, statistical research and focused patient services. The main office of the Society is located at #310 San Rafael St. San Miguel Manila.. It is manned by 11 regular staff, 12 project based staff and about 50 volunteers. The organization has 15 Board of Trustees.
It was certified for 3 years on October 20, 2000 which lapsed on October 19, 2003. On June 28, 2004, it was renewed for 5 years which lapsed on June 27, 2009. Its third certification was granted a 5-year certification on August 11, 2010 which lapsed on July 9, 2015.
Its purposes, among others, are “to advance knowledge on cancer, combat the spread of the disease and to bring relief to those afflicted with cancer”. The Foundation’s programs now focus on the following areas:
1. DIRECT SERVICES – these are direct service to patients who require medical treatment and psycho-social counseling thru its Patient Navigation Program (PNaP), free consultation and referrals, mobile screening clinic for breast, cervical and prostate cancer and specialized training seminars for health workers and medical professionals on hospice care.
2. EDUCATION AND INFORMATION – this includes rounds of information and education campaign such as lectures, conferences, seminars and tri-media publicity and advertising which aims to instill cancer consciousness in the general public.
3. CANCER REGISTRY- this is a population -based cancer registry that covers the cities of Manila, Quezon, Pasay and Caloocan which is coordinated with the Dept. Of Health’s Rizal Cancer Registry. The registry provides baseline data on the incidence of cancer for Metro Manila and the Philippines.
The society operates nationwide. Its priority areas are the 4 cities in the Metro Manila and 26 provinces in the country where cancer prevalence is high.